Gaize, Inc., on the 17th of November, 2022, announced the completion of the world’s most extensive clinical research investigating cannabis impairment. Gaize’s portable, non-invasive testing apparatus was employed in the 350-person study to assess pupillary reflex and eye movement response alterations.
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…
The DEA has opened a new registration process for state-licensed medical cannabis manufacturers, distributors and…
This November gathering will bring psychedelic education into conversation with music, visual art, comedy, philosophy,…
Ten p.m. on a Glendale balcony, two floors above the theater that just screened the…
We analyzed seven different 2026 rankings to find the true top 10 cannabis strains in…
A land-rooted look at the growers reshaping cannabis through living soil, ecological intelligence and regenerative…